Compare Elevation Biotech vs Receptor Biologix
Customers evaluate the quality of Elevation Biotech's products using the following success metrics.
Overview
Elevation Biotech is based in South Africa
Elevation Biotech specialises in the design and discovery of small peptide and peptidomimetic HIV attachment inhibitors. The company have developed biochemical and virological in vitro assays that screen specifically for the ability of compounds to block or interfere with viral attachment to the cell surface receptor CD4. The company's lead compound, is a short 7 amino acid peptide that binds to HIV envelope protein gp120 thereby preventing attachment of virus to the CD4 molecule.
Receptor Biologix is 21 yrs old and is based in United States.
Receptor BioLogix, Inc. is a biopharmaceutical company focused on the development and commercialization of a newly discovered class of protein therapeutics called Intron Fusion Proteins (IFP) to treat cancer, autoimmune, metabolic and other diseases.
Demo Video
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Elevation Biotech has not claimed their profile.
Work for Elevation Biotech? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Elevation Biotech?
Claim your profile now.
Information not available because Receptor Biologix has not claimed their profile.
Work for Receptor Biologix? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Receptor Biologix?
Claim your profile now.